↓ Skip to main content

Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms

Overview of attention for article published in American Journal of Hematology, May 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms
Published in
American Journal of Hematology, May 2019
DOI 10.1002/ajh.25489
Pubmed ID
Authors

Elisa Rumi, Silvia Zibellini, Emanuela Boveri, Chiara Cavalloni, Roberta Riboni, Ilaria Carola Casetti, Michele Ciboddo, Chiara Trotti, Cristina Favaron, Daniela Pietra, Chiara Candido, Virginia Valeria Ferretti, Mario Cazzola, Luca Arcaini

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 25%
Researcher 2 13%
Student > Doctoral Student 1 6%
Student > Ph. D. Student 1 6%
Other 1 6%
Other 0 0%
Unknown 7 44%
Readers by discipline Count As %
Medicine and Dentistry 4 25%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Business, Management and Accounting 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Agricultural and Biological Sciences 1 6%
Other 1 6%
Unknown 7 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2020.
All research outputs
#6,942,504
of 24,220,739 outputs
Outputs from American Journal of Hematology
#1,182
of 3,529 outputs
Outputs of similar age
#123,737
of 354,584 outputs
Outputs of similar age from American Journal of Hematology
#26
of 52 outputs
Altmetric has tracked 24,220,739 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 3,529 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,584 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.